Prepping for future pandemics: MERS vaccine candidate shows long-lasting immune response

A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination. The…

Continue Reading

News Source: medicalxpress.com